Surprise: FDA Panel Unable to Reach Conclusion on Genetically Modified Salmon

After two days of hearings, several members of an 11-member advisory panel of the U.S. Food and Drug Administration found that there are not yet sufficient data to determine that a genetic modification that enables salmon to grow twice as quickly is safe for the affected fish or for consumers. The panel, made up of outside experts, did not vote or make a recommendation on whether to approve these fish for human consumption, after holding today's public hearing to determine whether genetic...Full Story
Commenting on this article is closed.